QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
